Guidelines

• Biosafety
• Cancer
• Group A Streptococcal Disease
• Hepatitis C
• HIV/AIDS
• Infection Control
• Laboratory
• Sexually Transmitted Infections (STI)
• Travel Health/Quarantine
• Tuberculosis (TB)
• Vaccines and Vaccine-Preventable Diseases
• Publication Notes

Information on SARS for Health Professionals
www.sars.gc.ca

Biosafety

	Laboratory Biosafety Guidelines - 3rd Edition (2004)
	Laboratory Biosafety Guidelines (1996)
	Material Safety Data Sheets (MSDS) (1997)
	Guidelines for Biomedical Facilities using Sheep as Research Animals (2000)

Cancer

	Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (Updated October 2000)
	Use of Cancer Patient Information for Surveillance Purposes A Systematic Review of Legislation, Regulations, Policies and Guidelines (2000)
	Programmatic Guidelines for Screening for Cancer of the Cervix in Canada (1998)
	Lung Cancer: Guidelines for processing Specimens and Reporting Tumor Stage (2000)

Group A Streptococcal Disease

Guidelines for the Prevention and Control of Invasive Group A Streptococcal Disease (October 2006)

Hepatitis C

	Management of Viral Hepatitis: A Canadian Consensus Conference 2003/2004 - Evaluation Questionnaire - only
	Hepatitis C: Nutrition Care - Canadian Guidelines for Health Care Providers (September 2003)
	Nutrition Tips for People with Hepatitis C:    Helping You Feel Your Best!    Dealing With Discomforts    (September 2003)
	Hepatitis C: A Nursing Guide (September 2002)
	Management of Viral Hepatitis: Recommended Guidelines for Physicians (2000)
	Management Guidelines for the HCV-HIV Co-infected Adult (October 2000) -Executive Summary
	Reproductive Care of Women Living with Hep C Infection (October 2000)
	The Management of Viral Hepatitis. Proceedings of a consensus conference held in Montreal, Quebec in March 1999

HIV/AIDS

	Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS) (1996) (*)
	Guidelines for the Identification, Investigation and Treatment of Individuals with Concomitant Tuberculosis and HIV Infection (1992)

Infection Control

	Anaphylaxis: Statement on Initial Management in Non-hospital Settings (1995)
	Controlling Antimicrobial Resistance (1997) (*)
	Laboratory Biosafety Guidelines (1996)
	Proceedings of the Consensus Conference on Infected Health Care Workers: Risk for Transmission of Bloodborne Pathogens (July 1998) (*)
	Preventing The Transmission Of Bloodborne Pathogens In Health Care And Public Service Settings (May 1997) (*)
	An integrated protocol to manage health care workers exposed to bloodborne pathogens (March 1997) (*)
	Classic Creutzfeldt-Jakob Disease in Canada (2002) (*)
	Advisory Notice: Infection Control for Creutzfeldt-Jakob Disease (1996) (*)
	Foot Care by Health Care Providers (1997) (*)
	Infection Control Guidelines - Hand Washing, Cleaning, Disinfection and Sterilization in Health Care (362 KB) in PDF Format Only
	Hepatitis C - Prevention and Control: A Public Health Consensus (June 1999)
	Guidelines and Recommendations on the Prevention and Control of Hepatitis C (1995) (222 KB) in PDF Format Only
	Preventing Infections Associated with Indwelling Intravascular Access Devices (1997) (*)
	Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Health Care - Revision of Isolation and Precaution Techniques (1999) (*)
	Guidelines for Control of Meningococcal Disease (1994)
	Construction-related Nosocomial Infections in Patients in Health Care Facilities: Decreasing the Risk of Aspergillus, Legionella and Other Infections
	Prevention and Control of Occupational Infections in Health Care (2002)
	Infection Prevention and Control Practices for Personal Services: Tattooing, Ear/Body Piercing, and Electrolysis (1999) (*)
	A National Consensus on Guidelines for Establishment of a Post-Exposure Notification Protocol for Emergency Responders (1995) (132 KB) in PDF Format Only (*)
	Infection Control Guidance in a Non-Outbreak Setting, (In the Absence of SARS) When an Individual Presents to a Health Care Institution With a Respiratory Infection (2003-12-17) (144 KB) in PDF Format Only (*)
	Infection Control Guidance if there is a SARS Outbreak Anywhere in the World, When an Individual Presents to a Health Care Institution With a Respiratory Infection (2003-12-17) (146 KB) in PDF Format Only (*)
	Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings (1996) (*)
	Preventing the Spread of Vancomycin-Resistant Enterococci (VRE) in Canada (1997) (*)
	Canadian Contingency Plan for Viral Hemorrhagic Fevers and Other Related Diseases (1997) (*)

Laboratory

	Canadian External Quality Assessment - Advisory Group on Antibiotic Resistance (CEQA-AGAR) (1999)
	Laboratory Biosafety Guidelines - 3rd Edition (2004)
	Laboratory Biosafety Guidelines (1996)
	Material Safety Data Sheets (MSDS) (1997)
	Measles Surveillance: Guidelines for Laboratory Support (1999) (*)
	Guidelines for Biomedical Facilities using Sheep as Research Animals (2000)

Sexually Transmitted Infections (STI)

	Canadian Guidelines on Sexually Transmitted Infections 2006 Edition
	Lymphogranuloma venereum (LGV) in Canada: Recommendations for Diagnosis and Treatment and Protocol for National Enhanced Surveillance (May 2005)
	Canadian Guidelines for Sexual Health Education (2003)
	UPDATE: Information on the Availability in Canada of Cefixime (Suprax) for the treatment of Gonorrhea (November 2003)
	Information on the Availability in Canada of Cefixime (Suprax) for the treatment of Gonorrhea (December 2002)
	Update on the Availability in Canada of Bicillin (benzathine penicillin G) for the Treatment of Syphilis (May 2002)
	Interim Recommendations: Alternatives to Spectinomycin for Gonorrhea Treatment (September 2001) (92 KB) in PDF Format Only
	A Report from Consultations on a Framework for Sexual and Reproductive Health (1999)

Travel Health/Quarantine

	Statement on Personal Protective Measures to Prevent Arthropod Bites (2005)
	Statement on Oral Cholera Vaccination (1998) (*)
	Dengue Fever and International Travel (1996) (*)
	Persistent Diarrhea In The Returned Traveller (1998)
	Statement on Japanese Encephalitis Vaccine (1998)
	Statement on Ethics and Travel (2003)
	Evidence-Based Medicine (1994) (112 KB) in PDF Format Only
	Fever in The International Traveller - Initial Assessment Guidelines (1997) (*)
	Statement on High Altitude Illnesses (1998) (*)
	Statement on Travellers and HIV/AIDS (1994)
	Immunization Recommendations for Travellers
	Statement On Travel, Influenza, And Prevention - Update (2005) (*)
	Statement on Travel, Influenza, and Prevention (2005) (*)
	Travel, Influenza and Prevention (1996) (*)
	Travel Statement on Jet Lag (2003)
	Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers (2004) (*)
	Statement on Meningococcal Vaccination for Travellers (1999)
	Statement on Motion Sickness (2003)
	Statement on Motion Sickness (1996) (*)
	Poliomyelitis Vaccination for International Travellers (2003)
	Statement on Poliomyelitis Vaccination for International Travellers (1995)
	Statement on Travellers and Rabies Vaccine (2002)
	Guidelines for the Practice of Travel Medicine (1999)
	The Risk and Prevention of Tuberculosis in Travellers (1997) (*)
	Tuberculosis Screening and the International Traveller (1996) (*)
	Guidelines for the Investigation of Individuals Who Were Placed Under Surveillance for Tuberculosis Post-Landing in Canada (1992)
	Statement on Overseas Travellers and Typhoid (1994)
	Canadian Contingency Plan for Viral Hemorrhagic Fevers and Other Related Diseases (1997) (*)

Tuberculosis (TB)

	Guidelines regarding departure from Canada of persons with suspected respiratory tuberculosis (TB), untreated active respiratory TB or partially treated active respiratory TB - (Version 2006.07.18)
	Statement on Bacille Calmette Guérin (BCG) Vaccine (2004)
	Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary (2003)
	Recommendations for the Screening and Prevention of Tuberculosis in Patients with HIV and the Screening for HIV in Tuberculosis Patients and Their Contacts (2002)
	Canadian guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arrival in Canada (2001)
	Mycobacterium tuberculosis - Material Safety Data Sheet - Infectious Substances (2001)
	Canadian Tuberculosis Standards, 5th Edition (2000)
	Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis (1998)
	Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and other Institutional Settings (1996)

Vaccines and Vaccine-Preventable Diseases

	Adverse Events (associated with vaccines)
		Guidelines for Reporting Adverse Events Associated with Vaccine Products (2000)
	Cholera
		Statement on Oral Cholera Vaccination (1998) (*)
	Cochlear Implant Recipients
		Immunization Recommendations for Cochlear Implant Recipients (2003)
	Diptheria
		Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)
		Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (May 2000) (*)
		Guidelines for the Control of Diphtheria in Canada (July 1998) (*)
	Encephalitis
		Statement on Japanese Encephalitis Vaccine (1998)
	Haemophilus Influenzae Type B
		Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)
		Supplementary Statement on Newly Licensed Haemophilus Influenzae Type B (Hib) Conjugate Vaccines in Combination with other Vaccines Recommended for Infants (1994)
	Hepatitis
		Hepatitis B Vaccine, Update to the 2002 Canadian Immunization Guide 15 May 2004
		Update on Hepatitis A Vaccine (AVAXIM®, Aventis Pasteur), 2001 (*)
		Statement on Alternate Adolescent Schedule for Hepatitis B Vaccine, 2000 (*)
		Supplementary Statement on Hepatitis A Vaccine, 2000 (*)
		Statement on Combination Vaccines Against Hepatitis A And Hepatitis B (1999) (*)
		Supplementary Statement on Hepatitis Prevention - Hepatitis A and Hepatitis B Combination Vaccine for Children (1999) (*)
		Supplementary Statement on Hepatitis Prevention (1997) (*)
		Supplementary Statement on Hepatitis A Prevention (1996) (*)
		Report of the Hepatitis B Working Group (1994)
	Immunization
		Canadian Immunization Guide, Sixth Edition, 2002 (*) in PDF Format
		Guidelines For Childhood Immunization Practices
		Immunization Recommendations for Travellers
		Canadian National Report on Immunization, 1996
	Influenza
		Travel, Influenza, and Prevention (2005)
		Statement on Influenza Vaccination for the 2005-2006 Season (2005)
		Statement on Influenza Vaccination for the 2004-2005 Season (2004)
		Update: Statement on Influenza Vaccination for the 2003-2004 Season (2004)
		Statement on Influenza Vaccination for the 2003-2004 Season (2003)
		Statement on Influenza Vaccination for the 2002-2003 Season (2002)
		Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-respiratory syndrome in Association with Influenza Vaccination (2002)
		Statement on Influenza Vaccination for the 2001-2002 Season (2001)
		Travel, Influenza and Prevention (1996) (*)
	Measles
		Measles Surveillance: Guidelines for Laboratory Support (1998) (*)
		Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS) (1996) (*)
		Supplementary Statement on Measles Elimination in Canada (1996) (*)
		Guidelines for Control of Measles Outbreaks in Canada (1995)
	MMR (Measles, Mumps, Rubella)
		Supplementary Statement on MMR Vaccine and Anaphylactic Hypersensitivity to Egg or Egg-Related Antigens (1996) (*)
	Meningococcal
		Guidelines for the Prevention and Control of Meningococcal Disease - Supplement (2005)
		Update on Meningococcal C Conjugate Vaccines (2005)
		Supplementary Statement on Conjugate Meningococcal Vaccines (2003)
		Statement on Recommended Use of Meningococcal Vaccines (2001) (*)
		Statement on Meningococcal Vaccination for Travellers (1999)
	Palivizumab
		Statement on the Recommended use of Monoclonal Anti-RSV Antibody (Palivizumab) (2003)
	Pertussis
		Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)
		Clarification - Prevention of Pertussis in Adolescents and Adults (2004)
		National Consensus Conference on Pertussis (2003)
		Prevention of Pertussis in Adolescents and Adults (2003)
		Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (2000) (*)
		Statement on Pertussis Vaccine (1997) (*)
		Statement on Management of Persons Exposed to Pertussis and Pertussis Outbreak Control (1994)
	Pneumococcal
		Recommendations for use of Pneumococcal 23-Valent Polysaccharide Vaccine During Shortage (2004)
		Statement on the Recommended use of Pneumococcal Conjugate Vaccine: Addendum (2003)
		Statement on Recommended use of Pneumococcal Conjugate Vaccine (2002)
	Poliomyelitis
		Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)
		Poliomyelitis Vaccination for International Travellers (2003)
		Statement on Poliomyelitis Vaccination for International Travellers (1995)
	Rabies
		Update on Rabies Vaccines (2005)
		Statement on Travellers and Rabies Vaccine (1994)
	Smallpox
		Statement on Smallpox Vaccination (2002)
	Tetanus
		Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age  (2005)
		Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (May 2000) (*)
	Thimerosal
		Updated Recommendations on the use of Thimerosal-Containing Vaccines in Canada (2005-12-01)
		Statement on Thimerosal (2003)
		Thimerosal in Vaccines (1999)
	Vaccine
		Guidelines for Reporting Adverse Events Associated with Vaccine Products (2000)
		National Guidelines for Vaccine Storage and Conservation (1995) (201 KB) in PDF Format Only
	Varicella
		Update on Varicella (2004)
		NACI Update to Statement on Varicella Vaccine (2002)
		Statement on Recommended Use of Varicella Virus Vaccine (1999) (*)

* The guidelines are posted in collaboration with the Canadian Medical Association's Clinical Practice Guidelines Infobase. Hard copies of those with an (*) can be bought directly from the CMA.

Notes

• The following guidelines have been published by PHAC to support Canada's disease prevention and control efforts. Many of them contain recommendations on specific public health topics issued either by the National Advisory Committee on Immunization (NACI), the Committee to Advise on Tropical Medicine and Travel (CATMAT) or the Advisory Committee on Epidemiology (ACE) as well as by numerous expert and scientific groups who collaborate with PHAC.

• Within each category, the guidelines are classified alphabetically by main topic or disease condition (appearing in bold) and then by year.

• Most publications on these pages are viewable with web browsers. Some of the publications are available in PDF format. Please see here for information on how to download PDF files.

• Disclaimer: Each document has been carefully marked up for posting on the web. In the event of a discrepancy with the original printed version, the latter prevails.

• © Copyright: retained by the Crown.